/Investor DB

Humboldt — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOCV PartnersOMX Ventures+2 more

Mission Barnsmissionbarns.comin𝕏Nov 2018

Mission Barns produces cultivated meat products, primarily pork-based items like meatballs, bacon, and sausages, combining lab-grown pork fat with plant protein for consumers seeking sustainable alternatives to conventional meat.

Climate TechFoodTechBerkeley, US

Ilan Eitan Fischer(Executive Officer, Director)Eitan Fischer(Founder)

BoardDavid Bowman(Founder)

Co-investorsAir Street CapitalBabel VenturesBetter Ventures Central LlcBloom8Blue Ledge CapitalGaingels+9 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.